NRIX today
$15.87-$0.46 (-2.82%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $28.23
Key levels
Resistance$20.18
Resistance$18.10
Support$14.78
Latest news & SEC filings
NewsNurix Therapeutics picks physician Arati V. Rao to lead medical affairs
NewsArk Invest buys shares of Nurix Therapeutics
ProductNurix Therapeutics to present new bexobrutideg data at 68th ASH Annual Meeting
All NRIX news →About Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company in the clinical stage of development that creates medicines based on targeted protein degradation. Its main candidates include bexobrutideg and zelebrudomide, which break down BTK and related proteins to treat blood cancers, and NX-1607, which targets CBL-B for solid tumors. It also has earlier-stage programs for degrader antibody conjugates and works with partners such as Gilead, Sanofi, and Pfizer. The company is based in the United States.
Based on the company's 10-K filed Jan 28, 2026.
Nasdaq · Healthcare
Nurix Therapeutics, Inc. (NRIX)
What Is the Price Target for NRIX?
SEPT Low Target
$20.00
SEPT Mid Target
$34.00
SEPT High Target
$45.00
Analyst Consensus
$34.00
Is NRIX a Buy or Sell Right Now?
Thesis
- •Revenue growing 54.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NRIX.
Start Free Trial →Is NRIX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$32.52
57
Moat Score
NARROW
3/9
Piotroski Score
2.9
Altman Z-Score
What Is Smart Money Doing with NRIX?
Insider Signal
SELLING
0 buys / 14 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| van Houte Hans | officer | Sale | 3,300 | $51K | Nov 4, 2026 |
| van Houte Hans | officer | Sale | 1,469 | $24K | Nov 4, 2026 |
| Ring Christine | officer | Sale | 6,113 | $158K | Nov 3, 2026 |
| Ring Christine | officer | Buy | 5,786 | $50K | Nov 2, 2026 |
| Ring Christine | officer | Sale | 9,527 | $245K | Nov 2, 2026 |
| Ring Christine | officer | Sale | 1,075 | $29K | Nov 2, 2026 |
| Hansen Gwenn | officer | Buy | 1,452 | $3K | Oct 15, 2026 |
| Hansen Gwenn | officer | Sale | 1,452 | $36K | Oct 15, 2026 |
| GREGORY JULIA P | director | Buy | 22,583 | $42K | Oct 14, 2026 |
| GREGORY JULIA P | director | Sale | 22,583 | $529K | Oct 14, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NRIX Growth Story
Revenue YoY
54.0%
3yr Revenue CAGR
29.6%
EPS Growth YoY
-5.9%
FCF Growth YoY
-44.9%
Revenue Trend
STRONG
Dark Pool Trades for NRIX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NRIX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:57:17 | $15.86 | 1,000 | $$16K | MIDPOINT |
| 14:45:05 | $15.88 | 3,000 | $$48K | BUY |
| 14:42:06 | $15.90 | 1,000 | $$16K | BUY |
| 14:40:52 | $15.94 | 2,000 | $$32K | MIDPOINT |
| 14:40:01 | $15.90 | 2,245 | $$36K | SELL |
5 dark pool trades shown · $$147K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About NRIX
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for NRIX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $GDS — Wojtaszek Gary J | Sale $NRIX — GREGORY JULIA P | Sale $42K $NRIX — GREGORY JULIA P | Sale $529K $YTRA — Kaufman Michael A | Sale $BPRE — KAMFAR RAMIN | Sale $2.0M
Join 3,500+ traders discussing NRIX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Nurix Therapeutics, Inc. (NRIX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NRIX — frequently asked questions
What is NRIX stock price today?
Nurix Therapeutics, Inc. (NRIX) is at $15.87, down 2.82% (-$0.46) at the Nov 12, 2026 close.
Why is NRIX stock moving today?
Latest NRIX news — Nov 11, 2026: Nurix Therapeutics picks physician Arati V. Rao to lead medical affairs · Nov 9, 2026: Ark Invest buys shares of Nurix Therapeutics
Why did NRIX stock move on Oct 13, 2026?
Nurix Therapeutics shares closed at $22.12, down 0.18% on volume of 2.69 million, after trading between $21.75 and $23.24. The stock saw a wave of analyst activity, with Oppenheimer raising its price target to $32 and Baird raising its target to $36, both maintaining Outperform ratings.
What is the NRIX price target?
The average analyst price target for NRIX is $34.00, ranging from $20 to $45, based on 14 analysts. Latest: Wells Fargo maintains on Nov 4, 2026.
What do analysts rate NRIX?
Analyst ratings for NRIX: 13 Buy, 1 Hold, 0 Sell — consensus Buy.
Did NRIX beat earnings?
NRIX last reported on Oct 13, 2026: EPS $4.73 vs -$0.60 expected — a beat of 887.2%.
What is NRIX's P/E ratio?
NRIX trades at a P/E of 7.1 vs a Healthcare average of 17.3.
Does NRIX pay a dividend?
NRIX does not currently pay a dividend.
What are NRIX support and resistance levels?
Support: $14.78. Resistance: $18.10, $20.18, $22.10.
What are insiders doing with NRIX?
Insider activity: SELLING, 0 buys and 14 sells in the last 90 days.
What is the latest news on NRIX?
Nov 11, 2026: Nurix Therapeutics picks physician Arati V. Rao to lead medical affairs · Nov 9, 2026: Ark Invest buys shares of Nurix Therapeutics · Nov 5, 2026: Nurix Therapeutics to present new bexobrutideg data at 68th ASH Annual Meeting